135 related articles for article (PubMed ID: 2818278)
21. A double-masked comparison of carteolol and timolol in ocular hypertension.
Scoville B; Mueller B; White BG; Krieglstein GK
Am J Ophthalmol; 1988 Feb; 105(2):150-4. PubMed ID: 3277436
[TBL] [Abstract][Full Text] [Related]
22. The progress of the visual field in chronic simple glaucoma and ocular hypertension treated topically with pilocarpine or with timolol.
Crick RP; Newson RB; Shipley MJ; Blackmore H; Bulpitt CJ
Eye (Lond); 1990; 4 ( Pt 4)():563-71. PubMed ID: 2226985
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of carteolol hydrochloride 1% vs timolol maleate 0.5% in patients with increased intraocular pressure. Nocturnal Investigation of Glaucoma Hemodynamics Trial Study Group.
Stewart WC; Cohen JS; Netland PA; Weiss H; Nussbaum LL
Am J Ophthalmol; 1997 Oct; 124(4):498-505. PubMed ID: 9323940
[TBL] [Abstract][Full Text] [Related]
24. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
Franks WA; Renard JP; Cunliffe IA; Rojanapongpun P
Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448
[TBL] [Abstract][Full Text] [Related]
25. A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment Study.
Krupin T; Liebmann JM; Greenfield DS; Ritch R; Gardiner S;
Am J Ophthalmol; 2011 Apr; 151(4):671-81. PubMed ID: 21257146
[TBL] [Abstract][Full Text] [Related]
26. Long-term efficacy and safety of bimatoprost for intraocular pressure lowering in glaucoma and ocular hypertension: year 4.
Williams RD; Cohen JS; Gross RL; Liu CC; Safyan E; Batoosingh AL;
Br J Ophthalmol; 2008 Oct; 92(10):1387-92. PubMed ID: 18621791
[TBL] [Abstract][Full Text] [Related]
27. Latanoprost : an update of its use in glaucoma and ocular hypertension.
Perry CM; McGavin JK; Culy CR; Ibbotson T
Drugs Aging; 2003; 20(8):597-630. PubMed ID: 12795627
[TBL] [Abstract][Full Text] [Related]
28. The effect of d-timolol on intraocular pressure in patients with ocular hypertension.
Keates EU; Stone R
Am J Ophthalmol; 1984 Jul; 98(1):73-8. PubMed ID: 6742081
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study.
García-López A; Paczka JA; Jiménez-Román J; Hartleben C
BMC Ophthalmol; 2014 Dec; 14():161. PubMed ID: 25527295
[TBL] [Abstract][Full Text] [Related]
30. Long-term intraocular pressure-lowering efficacy and safety of timolol maleate gel-forming solution 0.5% compared with Timoptic XE 0.5% in a 12-month study.
Schenker HI; Silver LH
Am J Ophthalmol; 2000 Aug; 130(2):145-50. PubMed ID: 11004287
[TBL] [Abstract][Full Text] [Related]
31. Ocular hypertension: correlation of anterior chamber angle width and risk of progression to glaucoma.
Wishart PK; Batterbury M
Eye (Lond); 1992; 6 ( Pt 3)():248-56. PubMed ID: 1446756
[TBL] [Abstract][Full Text] [Related]
32. Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.
Netland PA; Landry T; Sullivan EK; Andrew R; Silver L; Weiner A; Mallick S; Dickerson J; Bergamini MV; Robertson SM; Davis AA;
Am J Ophthalmol; 2001 Oct; 132(4):472-84. PubMed ID: 11589866
[TBL] [Abstract][Full Text] [Related]
33. A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide.
Boyle JE; Ghosh K; Gieser DK; Adamsons IA
Ophthalmology; 1999 Dec; 106(12 Suppl):10-6. PubMed ID: 10598692
[TBL] [Abstract][Full Text] [Related]
34. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
Martínez A; Sánchez M
Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
[TBL] [Abstract][Full Text] [Related]
35. Safety and efficacy of bimatoprost/timolol fixed combination in Chinese patients with open-angle glaucoma or ocular hypertension.
Ling Z; Zhang M; Hu Y; Yin Z; Xing Y; Fang A; Ye J; Chen X; Liu D; Wang Y; Sun W; Dong Y; Sun X
Chin Med J (Engl); 2014; 127(5):905-10. PubMed ID: 24571886
[TBL] [Abstract][Full Text] [Related]
36. Comparison of aqueous and gellan ophthalmic timolol with placebo on the 24-hour heart rate response in patients on treatment for glaucoma.
Dickstein K; Hapnes R; Aarsland T
Am J Ophthalmol; 2001 Nov; 132(5):626-32. PubMed ID: 11704023
[TBL] [Abstract][Full Text] [Related]
37. A comparison of treated and untreated glaucoma suspects.
Schulzer M; Drance SM; Douglas GR
Ophthalmology; 1991 Mar; 98(3):301-7. PubMed ID: 2023749
[TBL] [Abstract][Full Text] [Related]
38. Double-masked comparative study of UF-021 and timolol ophthalmic solutions in patients with primary open-angle glaucoma or ocular hypertension.
Azuma I; Masuda K; Kitazawa Y; Takase M; Yamamura H
Jpn J Ophthalmol; 1993; 37(4):514-25. PubMed ID: 8145398
[TBL] [Abstract][Full Text] [Related]
39. Latanoprostene Bunod 0.024% versus Timolol Maleate 0.5% in Subjects with Open-Angle Glaucoma or Ocular Hypertension: The APOLLO Study.
Weinreb RN; Scassellati Sforzolini B; Vittitow J; Liebmann J
Ophthalmology; 2016 May; 123(5):965-73. PubMed ID: 26875002
[TBL] [Abstract][Full Text] [Related]
40. Topical bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension.
Easthope SE; Perry CM
Drugs Aging; 2002; 19(3):231-48. PubMed ID: 12027782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
